- Home
- SG vs ALKS Comparison
SG vs ALKS Comparison
Compare SG & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SG
- ALKS
- Stock Information
- Founded
- SG 2007
- ALKS 1987
- Country
- SG United States
- ALKS Ireland
- Employees
- SG N/A
- ALKS N/A
- Industry
- SG Restaurants
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- SG Consumer Discretionary
- ALKS Health Care
- Exchange
- SG Nasdaq
- ALKS Nasdaq
- Market Cap
- SG 4.7B
- ALKS 4.9B
- IPO Year
- SG 2021
- ALKS 1991
- Fundamental
- Price
- SG $36.87
- ALKS $30.96
- Analyst Decision
- SG Buy
- ALKS Buy
- Analyst Count
- SG 13
- ALKS 12
- Target Price
- SG $37.67
- ALKS $35.42
- AVG Volume (30 Days)
- SG 2.6M
- ALKS 1.5M
- Earning Date
- SG 11-07-2024
- ALKS 02-13-2025
- Dividend Yield
- SG N/A
- ALKS N/A
- EPS Growth
- SG N/A
- ALKS 55.25
- EPS
- SG N/A
- ALKS 1.97
- Revenue
- SG $668,948,000.00
- ALKS $1,505,121,000.00
- Revenue This Year
- SG $19.77
- ALKS N/A
- Revenue Next Year
- SG $16.71
- ALKS N/A
- P/E Ratio
- SG N/A
- ALKS $15.65
- Revenue Growth
- SG 21.72
- ALKS N/A
- 52 Week Low
- SG $9.66
- ALKS $22.90
- 52 Week High
- SG $45.12
- ALKS $32.88
- Technical
- Relative Strength Index (RSI)
- SG 44.54
- ALKS 60.07
- Support Level
- SG $34.16
- ALKS $30.08
- Resistance Level
- SG $39.20
- ALKS $31.18
- Average True Range (ATR)
- SG 2.39
- ALKS 0.76
- MACD
- SG -0.60
- ALKS -0.02
- Stochastic Oscillator
- SG 21.27
- ALKS 56.42
About SG Sweetgreen Inc.
Sweetgreen Inc is a next-generation restaurant and lifestyle brand that serves healthy food at scale. It is creating plant-forward, seasonal, and earth-friendly meals from fresh ingredients and produce that prioritizes organic, regenerative, and local sourcing.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.